Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p

Myasthenia gravis (MG) is an autoimmune neuromuscular disease characterized by fatigable skeletal muscle weakness with a fluctuating unpredictable course. One main concern in MG is the lack of objective biomarkers to guide individualized treatment decisions. Specific circulating serum microRNAs (miR...

Descripción completa

Detalles Bibliográficos
Autores principales: Beretta, Francesca, Huang, Yu-Fang, Punga, Anna Rostedt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870722/
https://www.ncbi.nlm.nih.gov/pubmed/35203389
http://dx.doi.org/10.3390/cells11040740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870722/
https://www.ncbi.nlm.nih.gov/pubmed/35203389
http://dx.doi.org/10.3390/cells11040740

Ejemplares similares